Sudan (the)

in page functions
[French]
Total population (2016) 41,175,337
Birth cohort (2016) 1,333,199
Surviving Infants (surviving to 1 year per year, 2016) 1,266,925
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 48/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 70/1000
World Bank Index, IDA (2012) 2.44
Co-financing status (2016) Preparatory transition
No. of districts/territories (2014) 174

Gavi support for Sudan

Type of support

Approvals

2001-2020 (US$)
(30 Apr 2016)

Commitments

2001-2020 (US$)
(30 Apr 2016)

Disbursements

2000-2016 (US$)
(30 Apr 2016)

% Disbursed

(30 Apr 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Health system strengthening (HSS 1) $16,153,500 $16,153,500 $16,153,500 100%
Health system strengthening (HSS 2) $15,833,652 $34,815,766 $9,885,620 62%
HepB mono (NVS) $3,027,132 $3,027,132 $3,027,132 100%
Immunisation services support (ISS) $11,229,380 $11,229,380 $10,598,300 94%
Injection safety support (INS) $1,321,257 $1,321,257 $1,321,257 100%
IPV (NVS) $2,837,649 $4,183,649 $2,837,649 100%
Meningitis A (NVS) $700,500 $700,500
Meningitis A - campaign (NVS) $16,988,586 $16,988,586 $16,988,586 100%
Meningitis A - mini catch-up campaign (NVS) $3,343,500 $3,343,500
Meningitis A - mini catch-up op.costs (OPC) $2,660,854 $2,660,854
Meningitis A - operational costs (OPC) $16,135,366 $16,135,366 $16,135,366 100%
Penta (NVS) $88,079,215 $88,079,215 $91,507,382 104%
Pneumo (NVS) $76,134,741 $76,134,741 $74,848,268 98%
Rotavirus (NVS) $32,379,253 $32,379,253 $30,915,885 95%
Vaccine Introduction Grant (VIG) $3,917,159 $3,917,159 $2,627,000 67%
Yellow Fever - campaign (NVS) $16,984,025 $41,088,525 $16,828,606 99%
YF - Operational costs (OPC) $7,937,302 $18,974,802 $7,937,302 100%
Total $315,663,071 $371,133,185 $301,611,853

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Sudan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 94%
M:F sex ratio at birth (2016) 1.04
Household survey: DTP3 coverage for male (2005) 53.70%
Household survey: DTP3 coverage for female (2005) 55.90%
Household survey: Last DTP3 survey (2009) 59%
% districts achieving > 80% DTP3 coverage (2014) 90%
% districts achieving < 50% DTP3 coverage (2014) 0%
MCV WHO/UNICEF estimates (2014) 86%

Breakdown of support

Non-vaccine support Vaccine support
21% 79%
$64,658,345 $236,953,505

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Sudan

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

12 November 2015

Mothers attending the launch ceremony of the PCV vaccine in Guinea Bissau, june 2015.

Unprecedented number of children protected against pneumonia with Gavi support

As the international community marks the seventh World Pneumonia Day, Gavi pneumococcal and pentavalent vaccines are reaching children at an accelerated pace.

10 November 2015

Gavi item

Scientists mark 'stunning success' of vaccine in virtually ridding Africa of meningitis A

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall.

close icon

modal window here